Phase III Study of ASP1941 Double-blind, Parallel-group Study in Combination With Insulin in Patients With Type 1 Diabetes Mellitus
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 11 Aug 2017
At a glance
- Drugs Ipragliflozin (Primary) ; Insulin
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 07 Aug 2017 Planned End Date changed from 1 Sep 2018 to 1 Mar 2018.
- 10 Jun 2017 Biomarkers information updated
- 19 Feb 2017 Status changed from recruiting to active, no longer recruiting.